Your browser doesn't support javascript.
loading
The inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway.
Jiao, X X; Lin, S Y; Lian, S X; Qiu, Y R; Li, Z H; Chen, Z H; Lu, W Q; Zhang, Y; Deng, L; Jiang, Y; Hu, G H.
Afiliação
  • Jiao XX; Baoshan branch, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Lin SY; School of Life Science, Nantong University, Nantong, China.
  • Lian SX; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qiu YR; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li ZH; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen ZH; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lu WQ; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang Y; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Deng L; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Jiang Y; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hu GH; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Neoplasma ; 67(4): 834-842, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32386478

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Tiazolidinedionas / Pioglitazona Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Neoplasma Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Tiazolidinedionas / Pioglitazona Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Neoplasma Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China